Partial Regression Of Primary Cutaneous Melanoma: Is There An Association With Sub-clinical Sentinel Lymph Node Metastasis? The American Journal Of Dermatopathology, 25(5), 371-376
Fontaine, D., Parkhill, W., Greer, W., & Walsh, N. (2003). Partial regression of primary cutaneous melanoma: Is there an association with sub-clinical sentinel lymph node metastasis? The American Journal of Dermatopathology, 25(5), 371-376.
View Original Source →Abstract
Over the past few years, the NCCN Guidelines for Melanoma: Cutaneous have been expanded to include pathways for treatment of microscopic satellitosis (added in v2.2020), and the following Principles sections: Molecular Testing (added in v2.2019), Systemic Therapy Considerations (added in v2.2020), and Brain Metastases Management (added in v3.2020). The v1.2021 update included additional modifications of these sections and notable revisions to Principles of: Pathology, Surgical Margins for Wide Excision of Primary Melanoma, Sentinel Lymph Node Biopsy, Completion/Therapeutic Lymph Node Dissection, and Radiation Therapy. These NCCN Guidelines Insights discuss the important changes to pathology and surgery recommendations, as well as additions to systemic therapy options for patients with advanced disease.
Case Details
No case details have been reported for this case.
Treatment & Mechanisms
No treatment or mechanism details have been reported for this case.